We are pleased to inform that the Company has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Helathcare (EDQM) Europe for its product Amlodipine Besilate.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]